HomeBusinessEli Lilly CEO on guidance cut, potential obesity drug, Alzheimer's study

Eli Lilly CEO on guidance cut, potential obesity drug, Alzheimer’s study

David Ricks, CEO, Eli Lilly

Scott Mlyn | CNBC

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

New Updates